# Reproductive Medicine Institute – FDA Inspection, Nov 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/d695808e-ab6b-4651-ad37-68fe824fa294
Source feed: FDA_Inspections

> FDA inspection 1073855 of Reproductive Medicine Institute, November 14, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073855
- Company Name: Reproductive Medicine Institute
- Inspection Date: 2018-11-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1306640 - 2026-03-09
- [FDA Inspection 814339 - 2013-01-18](https://www.keypedia.com/records/fda_inspections/reproductive-medicine-institute/13273626-c0ed-4cab-8034-6a5ada99c2db)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/uruaku-a-obasi/8ff0e6f4-da89-4ec0-86f4-7ebf8cf529b8)

Company: https://www.keypedia.com/companies/reproductive-medicine-institute/312d64b8-70da-4052-ad1e-ca19d42819e4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d